Blood biomarkers for evaluation of perinatal encephalopathy

Frontiers in Pharmacology

Volumn 7, Issue JUL, 2016, Pages

  Graham, Ernest M ^a   Burd, Irina ^a   Everett, Allen D ^a   Northington, Frances J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Glial injury; Hypoxic ischemic encephalopathy; Neonatal encephalopathy; Neuronal injury

Indexed keywords

ACTIVIN A; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; FREE RADICAL; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MALONALDEHYDE; MICRORNA; MICROTUBULE ASSOCIATED PROTEIN 2; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN S100B; SPECTRIN BREAKDOWN PRODUCT; SUPEROXIDE DISMUTASE; TAU PROTEIN; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN CARBOXY TERMINAL HYDROLASE L1 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

BLOOD; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN INJURY; EXOSOME; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFLAMMATION; METABOLISM; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REVIEW;

EID: 84981341473     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00196     Document Type: Review

References (104)

1. American College of Obstetricians Gynecologists, American Academy of Pediatrics. (2014). Neonatal Encephalopathy and Neurologic Outcome, 2nd Edn. Washington DC: American College of Obstetricians and Gynecologists.
2. Atkinson, A. J., Colburn, W. A., DeGruttola, V. G., DeMets, D. L., Downing, G. J., Hoth, D. F., et al. (2001). Biomarkers and surrogate endpoints. Perferred definitions and conceptual framework. Clin. Pharmacol. Therapeut. 69, 89-95. doi: 10.1067/mcp.2001.113989
3. Banks, W. A., Dohi, K., Hansen, K., and Thompson, H. J. (2016). Assessing blood granulocyte colony-stimulating factor as a potential biomarker of acute traumatic brain injury in mice and humans. Brain Behav. Immun. 52, 81-87. doi: 10.1016/j.bbi.2015.10.002
4. Banks, W. A., Gray, A. M., Erickson, M. A., Salameh, T. S., Damodarasamy, M., Sheibani, N., et al. (2015). Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J. Neuroinflammation 12:223. doi: 10.1186/s12974-015-0434-1
5. Barbarese, E., Barry, C., Chou, C. H., Goldstein, D. J., Nakos, G. A., Hyde-DeRuyscher, R., et al. (1988). Expression and localization of myelin basic protein in oligodendrocytes and transfected fibroblasts. J. Neurochem. 51, 1737-1745. doi: 10.1111/j.1471-4159.1988.tb01153.x
6. Berger, R. P., Beers, S. R., Richichi, R., Wiesman, D., and Adelson, P. D. (2007). Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J. Neurotrauma 24, 1793-1801. doi: 10.1089/neu.2007.0316
7. Biberthaler, P., Linsenmeier, U., Pfeifer, K. J., Kroetz, M., Mussack, T., Kanz, K. G., et al. (2006). Serum S-100B concentration provides additional information fot the indication of computed tomography in patients after minor head injury: a prospective multicenter study. Shock 25, 446-453. doi: 10.1097/01.shk.0000209534.61058.35
8. Bressan, S., Daverio, M., Martinolli, F., Dona', D, Mario, F., Steiner, I. P., et al. (2014). The use of handheld near-infrared device (infrascanner)for detecting intracranial haemorrhages in children with minor head injury. Childs. Nerv. Syst. 30, 477-484. doi: 10.1007/s00381-013-2314-2
9. Chalak, L. F., Sanchez, P. J., Adams-Huet, B., Laptook, A. R., Heyne, R. J., and Rosenfeld, C. R. (2014). Biomarkers for severity of neonatal hypoxic-ischemic encephalopathy and outcomes in newborns receiving hypothermia therapy. J. Pediatr. 164, 468-474.e1. doi: 10.1016/j.jpeds.2013.10.067
10. Chatfield, D. A., Zemlan, F. P., Day, D. J., and Menon, D. K. (2002). Discordant temporal patterns of S100beta and cleaved tau protein elevation after head injury: a pilot study. Br. J. Neurosurg. 16, 471-476. doi: 10.1080/0268869021000030285
11. Chen, F., Du, Y., Esposito, E., Liu, Y., Guo, S., Wang, X., et al. (2015). Effects of focal cerebral ischemia on exosomal versus serum miR126. Transl. Stroke Res. 6, 478-484. doi: 10.1007/s12975-015-0429-3
12. Chen, H., and Yang, T. T. (2012). Expression and significance of serum miRNA-21 control HIE-1a in newborn with asphyxia. Chin. J. Child Health Care 23, 32-34.
13. Covenas, R., Gonzalez-Fuentes, J., Rivas-Infante, E., Lagartos-Donate, M. J., Cebada-Sanchez, S., Arroyo-Jimenez, M. M., et al. (2014). Developmental study of the distribution of hypoxia-induced factor-1 alpha and microtubule-associated protein 2 in children's brainstem: comparison between controls and cases with signs of perinatal hypoxia. Neuroscience 271, 77-98. doi: 10.1016/j.neuroscience.2014.04.018
14. Dammann, O., and Leviton, A. (1997). Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr. Res. 42, 1-8. doi: 10.1203/00006450-199707000-00001
15. Diaz-Arrastia, R., Wang, K. K., Papa, L., Sorani, M. D., Yue, J. K., Puccio, A. M., et al. (2014). Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. J. Neurotrauma 31, 19-25. doi: 10.1089/neu.2013.3040
16. Dohi, K., Kraemer, B. C., Erickson, M. A., McMillan, P. J., Kovac, A., Flachbartova, Z., et al. (2014). Molecular hydrogen in drinking water protects against neurodegenerative changes induced by traumatic brain injury. PLoS ONE 9:e108034. doi: 10.1371/journal.pone.0108034
17. Dong, X. Q., Yu, W. H., Zhu, Q., Cheng, Z. Y., Chen, Y. H., Lin, X. F., et al. (2015). Changes in plasma thrombospondin-1 concentrations following acute intracerebral hemorrhage. Clin. Chim. Acta 450, 349-355. doi: 10.1016/j.cca.2015.09.013
18. Douglas-Escobar, M. V., Heaton, S. C., Bennett, J., Young, L. J., Glushakova, O., Xu, X., et al. (2014). UCH-L1 and GFAP serum levels in neonates with hypoxic-ischemic encephalopathy: a single center pilot study. Front. Neurol. 5:273. doi: 10.3389/fneur.2014.00273
19. Duggan, P. J., Maalouf, E. F., Watts, T. L., Sullivan, M. H., Counsell, S. J., Allsop, J., et al. (2001). Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 358, 1699-1700. doi: 10.1016/S0140-6736(01)06723-X
20. Egea, V., Schober, A., and Weber, C. (2012). Circulating miRNAs: messengers on the move in cardiovascular disease. Thromb. Haemost. 108, 590-591. doi: 10.1160/TH12-08-0613
21. Egea-Guerrero, J. J., Murillo-Cabezas, F., Gordillo-Escobar, E., Rodriguez-Rodriguez, A., Enamorado-Enamorado, J., Revuelto-Rey, J., et al. (2013). S100B protein may detect brain death development after severe traumatic brain injury. J. Neurotrauma 30, 1762-1769. doi: 10.1089/neu.2012.2606
22. Ennen, C. S., Huisman, T. A., Savage, W. J., Northington, F. J., Jennings, J. M., Everett, A. D., et al. (2011). Glial fibrillary acidic protein as a biomarker for neonatal hypoxic-ischemic encephalopathy treated with whole-body cooling. Am. J. Obstet. Gynecol. 251, e1-e7. doi: 10.1016/j.ajog.2011.06.025
23. Failla, M. D., Conley, Y. P., and Wagner, A. K. (2016). Brain-derived neurotrophic factor (BDNF) in traumatic brain injury-related mortality: interrelationships between genetics and acute systemic and central nervous system BDNF profiles. Neurorehabil. Neural Repair 30, 83-93. doi: 10.1177/1545968315586465
24. Fathali, N., Lekic, T., Zhang, J. H., and Tang, J. (2010). Long-term evaluation of granulocyte-colony stimulating factor on hypoxic-ischemic brain damage in infant rats. Intensive Care Med. 36, 1602-1608. doi: 10.1007/s00134-010-1913-6
25. Felderhoff-Mueser, U., Schmidt, O. I., Oberholzer, A., Buhrer, C., and Stahel, P. F. (2005). IL-18: A key player in neuroinflammation and neurodegeneration? Trends Neurosci. 28, 487-493. doi: 10.1016/j.tins.2005.06.008
26. Galea, E., Dupouey, P., and Feinstein, D. L. (1995). Glial fibrillary acidic protein mRNA isotypes: expression in vitro and in vivo. J. Neurosci. Res. 41, 452-461. doi: 10.1002/jnr.490410404
27. Gazzolo, D., Pluchinotta, F., Bashir, M., Aboulgar, H., Said, H. M., Iman, I., et al. (2015). Neurological abnormalities in full-term asphyxiated newborns and salivary S100B testing: the "cooperative multitask against brain injury of neonates" (CoMBINe) international study. PLoS ONE 10:e0115194. doi: 10.1371/journal.pone.0115194
28. Gradisek, P., Osredkar, J., Korsic, M., and Kremzar, B. (2012). Multiple indicators model of long-term mortality in traumatic brain injury. Brain Inj. 26, 1472-1481. doi: 10.3109/02699052.2012.694567
29. Guingab-Cagmat, J. D., Cagmat, E. B., Hayes, R. L., and Anagli, J. (2013). Integration of proteomics, bioinformatics, and systems biology in traumatic brain injury biomarker discovery. Front. Neurol. 4:61. doi: 10.3389/fneur.2013.00061
30. Guo, Y. H., Li, G. X., Li, W. H., Liu, Z. S., and Bai, X. M. (2014). Dynamic study of serum interleukin 18 levels in neonatal hypoxic ischemic encephalopathy. J. Hebei Med. Univ. 35, 105-108.
31. Herrmann, M., Jost, S., Kutz, S., Ebert, A. D., Kratz, T., Wunderlich, M. T., et al. (2000). Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J. Neurotrauma 17, 113-122. doi: 10.1089/neu.2000.17.113
32. Higuchi, M., Lee, V. M., and Trojanowski, J. Q. (2002). Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med. 2, 131-150. doi: 10.1385/NMM:2:2:131
33. Imam, S. S., Gad, G. I., Atef, S. H., and Shawky, M. A. (2009). Cord blood brain derived neurotrophic factor: diagnostic and prognostic marker in fullterm newborns with perinatal asphyxia. Pak. J. Biol. Sci. 12, 1498-1504. doi: 10.3923/pjbs.2009.1498.1504
34. Ingebrigtsen, T., Waterloo, K., Jacobsen, E. A., Langbakk, B., and Romner, B. (1999). Traumatic brain damage in minor head injury: relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 45, 468-475; discussion 475-6. doi: 10.1097/00006123-199909000-00010
35. Isgro, M. A., Bottoni, P., and Scatena, R. (2015). Neuron-specific enolase as a biomarker: biochemical and clinical aspects. Adv. Exp. Med. Biol. 867, 125-143. doi: 10.1007/978-94-017-7215-0_9
36. Jin, C., Londono, I., Mallard, C., and Lodygensky, G. A. (2015). New means to assess neonatal inflammatory brain injury. J. Neuroinflammation 12:180. doi: 10.1186/s12974-015-0397-2
37. Kobeissy, F. H., Sadasivan, S., Oli, M. W., Robinson, G., Larner, S. F., Zhang, Z., et al. (2008). Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation. Proteomics Clin. Appl. 2, 1467-1483. doi: 10.1002/prca.200800011
38. Korley, F. K., Diaz-Arrastia, R., Wu, A. H., Yue, J. K., Manley, G. T., Sair, H. I., et al. (2016). Circulating brain-derived neurotrophic factor has diagnostic and prognostic value in traumatic brain injury. J. Neurotrauma 33, 215-225. doi: 10.1089/neu.2015.3949
39. Lawn, J. E., Bahl, R., Bergstrom, S., Bhutta, Z. A., Darmstadt, G. L., Ellis, M., et al. (2011). Setting research priorities to reduce almost one million deaths from birth asphyxia by 2015. PLoS Med. 8:e1000389. doi: 10.1371/journal.pmed.1000389
40. Lee, A. C., Kozuki, N., Blencowe, H., Vos, T., Bahalim, A., Darmstadt, G. L., et al. (2013). Intrapartum-related neonatal encephalopathy incidence and impairment at regional and global levels for 2010 with trends from 1990. Pediatr. Res. 74, 50-72. doi: 10.1038/pr.2013.206
41. Lee, J. Y., Lee, C. Y., Kim, H. R., Lee, C. H., Kim, H. W., and Kim, J. H. (2015). A role of serum-based neuronal and glial markers as potential predictors for distinguishing severity and related outcomes in traumatic brain injury. J. Korean Neurosurg. Soc. 58, 93-100. doi: 10.3340/jkns.2015.58.2.93
42. Leviton, A. (1993). Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev. Med. Child Neurol. 35, 553-558.
43. Liang, Y. M., and Wang, H. (2005). The expression of VEGF and VEGF mRNA in hypoxic-ischemic brain injury. Chin. Pediatr. Emerg. Med. 12, 134-136.
44. Liu, H., Cheney, J., Li, X., Li, S., Sheng, H., Huo, R., et al. (2009). Changes and clinical significance of serum levels of MMP-9 and MMP-2 in newborns with hypoxic-ischemic encephalopathy. J. Clin. Pediatr. 27, 842-843.
45. Liu, J., and Feng, Z. C. (2010). Increased umbilical cord plasma interleukin-1 beta levels was correlated with adverse outcomes of neonatal hypoxic-ischemic encephalopathy. J. Trop. Pediatr. 56, 178-182. doi: 10.1093/tropej/fmp098
46. Loscher, W., Klitgaard, H., Twyman, R. E., and Schmidt, D. (2013). New avenues for anti-epileptic drug discovery and development. Nat. Rev. Drug Discov. 12, 757-776. doi: 10.1038/nrd4126
47. Lv, H., Wang, Q., Wu, S., Yang, L., Ren, P., Yang, Y., et al. (2015). Neonatal hypoxic ischemic encephalopathy-related biomarkers in serum and cerebrospinal fluid. Clin. Chim. Acta 450, 282-297. doi: 10.1016/j.cca.2015.08.021
48. Massaro, A. N., Jeromin, A., Kadom, N., Vezina, G., Hayes, R. L., Wang, K. K., et al. (2013). Serum biomarkers of MRI brain injury in neonatal hypoxic ischemic encephalopathy treated with whole-body hypothermia: a pilot study. Pediatr. Crit. Care Med. 14, 310-317. doi: 10.1097/PCC.0b013e3182720642
49. Merchant, N., and Azzopardi, D. (2015). Early predictors of outcome in infants treated with hypothermia for hypoxic-ischaemic encephalopathy. Dev. Med. Child Neurol. 57, 8-16. doi: 10.1111/dmcn.12726
50. Mondello, S., Gabrielli, A., Catani, S., D'Ippolito, M., Jeromin, A., Ciaramella, A., et al. (2012c). Increased levels of serum MAP-2 at 6-months correlate with improved outcome in survivors of severe traumatic brain injury. Brain Inj. 26, 1629-1635. doi: 10.3109/02699052.2012.700083
51. Mondello, S., Jeromin, A., Buki, A., Bullock, R., Czeiter, E., Kovacs, N., et al. (2012a). Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. J. Neurotrauma 29, 1096-1104. doi: 10.1089/neu.2011.2092
52. Mondello, S., Linnet, A., Buki, A., Robicsek, S., Gabrielli, A., Tepas, J., et al. (2012b). Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury. Neurosurgery 70, 666-675. doi: 10.1227/NEU.0b013e318236a809
53. Mondello, S., Papa, L., Buki, A., Bullock, M. R., Czeiter, E., Tortella, F. C., et al. (2011). Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study. Crit. Care 15:R156. doi: 10.1186/cc10286
54. Mouhieddine, T. H., El Houjeiri, L., Sabra, M., Hayes, R. L., and Mondello, S. (2015). "CNS trauma biomarkers and surrogate endpoints pipeline from bench to bedside: a translational perspective," in Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects, ed F. H. Kobeissy (Boca Raton, FL: CRC Press/Taylor & Francis).
55. Mukerji, S. S., Katsman, E. A., Wilber, C., Haner, N. A., Selman, W. R., and Hall, A. K. (2007). Activin is a neuronal survival factor that is rapidly increased after transient cerebral ischemia and hypoxia in mice. J. Cereb. Blood Flow Metab. 27, 1161-1172. doi: 10.1038/sj.jcbfm.9600423
56. Nagdyman, N., Komen, W., Ko, H. K., Muller, C., and Obladen, M. (2001). Early biochemical indicators of hypoxic-ischemic encephalopathy after birth asphyxia. Pediatr. Res. 49, 502-506. doi: 10.1203/00006450-200104000-00011
57. Nelson, K. B., Grether, J. K., Dambrosia, J. M., Walsh, E., Kohler, S., Satyanarayana, G., et al. (2003). Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr. Res. 53, 600-607. doi: 10.1203/01.PDR.0000056802.22454.AB
58. Niogi, S. N., and Mukherjee, P. (2010). Diffusion tensor imaging of mild traumatic brain injury. J. Head Trauma Rehabil. 25, 241-255. doi: 10.1097/HTR.0b013e3181e52c2a
59. Okumus, N., Turkyilmaz, C., Onal, E. E., Atalay, Y., Serdaroglu, A., Elbeg, S., et al. (2008). Tau and s-100B proteins as biochemical markers of bilirubin-induced neurotoxicity in term neonates. Pediatr. Neurol. 39, 245-250. doi: 10.1016/j.pediatrneurol.2008.07.004
60. Ottens, A. K., Golden, E. C., Bustamante, L., Hayes, R. L., Denslow, N. D., and Wang, K. K. (2008). Proteolysis of multiple myelin basic protein isoforms after neurotrauma: characterization by mass spectrometry. J. Neurochem. 104, 1404-1414. doi: 10.1111/j.1471-4159.2007.05086.x
61. Papa, L., Robinson, G., Oli, M., Pineda, J., Demery, J., Brophy, G., et al. (2008). Use of biomarkers for diagnosis and management of traumatic brain injury patients. Expert Opin. Med. Diagn. 2, 937-945. doi: 10.1517/17530059.2.8.937
62. Patz, S., Trattnig, C., Grunbacher, G., Ebner, B., Gully, C., Novak, A., et al. (2013). More than cell dust: microparticles isolated from cerebrospinal fluid of brain injured patients are messengers carrying mRNAs, miRNAs, and proteins. J. Neurotrauma 30, 1232-1242. doi: 10.1089/neu.2012.2596
63. Petrov, I. Y., Petrov, Y., Prough, D. S., Cicenaite, I., Deyo, D. J., and Esenaliev, R. O. (2012a). Optoacoustic monitoring of cerebral venous blood oxygenation though intact scalp in large animals. Opt. Express 20, 4159-4167. doi: 10.1364/OE.20.004159
64. Petrov, I. Y., Petrov, Y., Prough, D. S., Deyo, D. J., Cicenaite, I., and Esenaliev, R. O. (2012b). Optoacoustic monitoring of cerebral venous blood oxygenation through extracerebral blood. Biomed. Opt. Express 3, 125-136. doi: 10.1364/BOE.3.000125
65. Pierrat, V., Haouari, N., Liska, A., Thomas, D., Subtil, D., Truffert, P., et al. (2005). Prevalence, causes, and outcome at 2 years of age of newborn encephalopathy: population based study. Arch. Dis. Child. Fetal Neonatal Ed. 90, F257-F261. doi: 10.1136/adc.2003.047985
66. Pineda, J. A., Lewis, S. B., Valadka, A. B., Papa, L., Hannay, H. J., Heaton, S. C., et al. (2007). Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24, 354-366. doi: 10.1089/neu.2006.003789
67. Qian, J., Zhou, D., and Wang, Y. W. (2009). Umbilical artery blood S100beta protein: a tool for the early identification of neonatal hypoxic-ischemic encephalopathy. Eur. J. Pediatr. 168, 71-77. doi: 10.1007/s00431-008-0711-4
68. Qin, L. N., Feng, A. H., Yang, C. H., and Xing, H. Y. (2005). Clinical values of superoxide dismutase and malondialdehyde detection in cord blood of newborns with fetal distress. Zhonghua Fu Chan Ke Za Zhi 40, 312-314.
69. Raabe, A., Grolms, C., Keller, M., Dohnert, J., Sorge, O., and Seifert, V. (1998). Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir. (Wien). 140, 787-791; discussion 791-2. doi: 10.1007/s007010050180
70. Rajendran, L., Bali, J., Barr, M. M., Court, F. A., Kramer-Albers, E. M., Picou, F., et al. (2014). Emerging roles of extracellular vesicles in the nervous system. J. Neurosci. 34, 15482-15489. doi: 10.1523/JNEUROSCI.3258-14.2014
71. Redell, J. B., Moore, A. N., Ward, N. H. III., Hergenroeder, G. W., and Dash, P. K. (2010). Human traumatic brain injury alters plasma microRNA levels. J. Neurotrauma 27, 2147-2156. doi: 10.1089/neu.2010.1481
72. Riederer, B. M., Zagon, I. S., and Goodman, S. R. (1986). Brain spectrin(240/235) and brain spectrin(240/235E): two distinct spectrin subtypes with different locations within mammalian neural cells. J. Cell Biol. 102, 2088-2097. doi: 10.1083/jcb.102.6.2088
73. Ringger, N. C., O'steen, B. E., Brabham, J. G., Silver, X., Pineda, J., Wang, K. K., et al. (2004). A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. J. Neurotrauma 21, 1443-1456. doi: 10.1089/neu.2004.21.1443
74. Roka, A., Kelen, D., Halasz, J., Beko, G., Azzopardi, D., and Szabo, M. (2012). Serum S100B and neuron-specific enolase levels in normothermic and hypothermic infants after perinatal asphyxia. Acta Paediatr. 101, 319-323. doi: 10.1111/j.1651-2227.2011.02480.x
75. Roncon, P., Soukupova, M., Binaschi, A., Falcicchia, C., Zucchini, S., Ferracin, M., et al. (2015). MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy-comparison with human epileptic samples. Sci. Rep. 5:14143. doi: 10.1038/srep14143
76. Rothoerl, R. D., and Woertgen, C. (2001). High serum S100B levels for trauma patients without head injuries. Neurosurgery 49, 1490-1491; author reply 1492-3. doi: 10.1097/00006123-200112000-00054
77. Saatman, K. E., Duhaime, A. C., Bullock, R., Maas, A. I., Valadka, A., Manley, G. T., et al. (2008). Classification of traumatic brain injury for targeted therapies. J. Neurotrauma 25, 719-738. doi: 10.1089/neu.2008.0586
78. Sagare, A. P., Sweeney, M. D., Makshanoff, J., and Zlokovic, B. V. (2015). Shedding of soluble platelet-derived growth factor receptor-beta from human brain pericytes. Neurosci. Lett. 607, 97-101. doi: 10.1016/j.neulet.2015.09.025
79. Schiering, I. A., de Haan, T. R., Niermeijer, J. M., Koelman, J. H., Majoie, C. B., Reneman, L., et al. (2014). Correlation between clinical and histologic findings in the human neonatal hippocampus after perinatal asphyxia. J. Neuropathol. Exp. Neurol. 73, 324-334. doi: 10.1097/NEN.0000000000000056
80. Schiff, L., Hadker, N., Weiser, S., and Rausch, C. (2012). A literature review of the feasibility of glial fibrillary acidic protein as a biomarker for stroke and traumatic brain injury. Mol. Diagn. Ther. 16, 79-92. doi: 10.1007/BF03256432
81. Selakovic, V., Raicevic, R., and Radenovic, L. (2005). The increase of neuron-specific enolase in cerebrospinal fluid and plasma as a marker of neuronal damage in patients with acute brain infarction. J. Clin. Neurosci. 12, 542-547. doi: 10.1016/j.jocn.2004.07.019
82. Setsuie, R., and Wada, K. (2007). The functions of UCH-L1 and its relation to neurodegenerative diseases. Neurochem. Int. 51, 105-111. doi: 10.1016/j.neuint.2007.05.007
83. Shang, Y., Mu, L., Guo, X., Li, Y., Wang, L., Yang, W., et al. (2014). Clinical significance of interleukin-6, tumor necrosis factor-alpha and high-sensitivity C-reactive protein in neonates with hypoxic-ischemic encephalopathy. Exp. Ther. Med. 8, 1259-1262. doi: 10.3892/etm.2014.1869
84. Skogseid, I. M., Nordby, H. K., Urdal, P., Paus, E., and Lilleaas, F. (1992). Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage. Acta Neurochir. (Wien). 115, 106-111. doi: 10.1007/BF01406367
85. Sobrino, T., Arias, S., Rodriguez-Gonzalez, R., Brea, D., Silva, Y., de la Ossa, N. P., et al. (2009). High serum levels of growth factors are associated with good outcome in intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 29, 1968-1974. doi: 10.1038/jcbfm.2009.182
86. Stewart, A., Tekes, A., Huisman, T. A., Jennings, J. M., Allen, M. C., Northington, F. J., et al. (2013). Glial fibrillary acidic protein as a biomarker for periventricular white matter injury. Am. J. Obstet Gynecol. 209, 27.e1-e7. doi: 10.1016/j.ajog.2013.02.049
87. Thelin, E. P., Johannesson, L., Nelson, D., and Bellander, B. M. (2013). S100B is an important outcome predictor in traumatic brain injury. J. Neurotrauma 30, 519-528. doi: 10.1089/neu.2012.2553
88. Thoresen, M., Hellstrom-Westas, L., Liu, X., and de Vries, L. S. (2010). Effect of hypothermia on amplitude-integrated electroencephalogram in infants with asphyxia. Pediatrics 126, e131-e139. doi: 10.1542/peds.2009-2938
89. Tian, J. C., and Yan, S. T. (2012). Determination and clinical significance of serum hs-CRF, TNF-a, MMP-9 in neonatal hypoxic ischemic encephalopathy. China Mod. Med. 19, 92-93.
90. Torricelli, A., Contini, D., Dalla Mora, A., Pifferi, A., Re, R., Zucchelli, L., et al. (2014). Neurophotonics: non-invasive optical techniques for monitoring brain functions. Funct. Neurol. 29:223. doi: 10.11138/fneur/2014.29.4.223
91. Unden, J., Ingebrigtsen, T., Romner, B., and Scandinavian Neurotrauma Committee(SNC) (2013). Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update. BMC Med. 11:50. doi: 10.1186/1741-7015-11-50
92. Vos, P. E., Lamers, K. J., Hendriks, J. C., van Haaren, M., Beems, T., Zimmerman, C., et al. (2004). Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 62, 1303-1310. doi: 10.1212/01.WNL.0000120550.00643.DC
93. Wang, Y. C., Shi, C. C., and Ni, H. (2003). Clinical significance of serum interleukin 10 levels in neonatal hypoxic ischemic encephalopathy. J. Appl. Clin. Pediatr. 18, 442-443.
94. Weiss, J. B., Eisenhardt, S. U., Stark, G. B., Bode, C., Moser, M., and Grundmann, S. (2012). MicroRNAs in ischemia-reperfusion injury. Am. J. Cardiovasc. Dis. 2, 237-247.
95. Welch, R. D., Ayaz, S. I., Lewis, L. M., Unden, J., Chen, J. Y., Mika, V. H., et al. (2016). Ability of serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury. J. Neurotrauma 33, 203-214. doi: 10.1089/neu.2015.4149
96. Werner, J. K., and Stevens, R. D. (2015). Traumatic brain injury: recent advances in plasticity and regeneration. Curr. Opin. Neurol. 28, 565-573. doi: 10.1097/WCO.0000000000000265
97. Wu, X. P., Zhang, L. X., Shen, Y. J., Liu, C. Y., and Wang, Z. J. (2012). Relationship between serum inflammatory factors and neonatal brain injury. Chin. J. Neonatol. 27, 180-182.
98. Yildiz, R., Coskun, U., Buyukberber, S., Sancak, B., Kaya, A. O., Gulbahar, O., et al. (2011). Serum granulocyte colony-stimulating factor levels in gliomas. J. BUON. 16, 138-141.
99. Yokobori, S., Hosein, K., Burks, S., Sharma, I., Gajavelli, S., and Bullock, R. (2013). Biomarkers for the clinical differential diagnosis in traumatic brain injury-a systematic review. CNS Neurosci. Ther. 19, 556-565. doi: 10.1111/cns.12127
100. Yoon, B. H., Jun, J. K., Romero, R., Park, K. H., Gomez, R., Choi, J. H., et al. (1997). Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am. J. Obstet Gynecol. 177, 19-26. doi: 10.1016/S0002-9378(97)70432-0
101. Youn, Y. A., Kim, S. J., Sung, I. K., Chung, S. Y., Kim, Y. H., and Lee, I. G. (2012). Serial examination of serum IL-8, IL-10 and IL-1Ra levels is significant in neonatal seizures induced by hypoxic-ischaemic encephalopathy. Scand. J. Immunol. 76, 286-293. doi: 10.1111/j.1365-3083.2012.02710.x
102. Yu, S. C., Kuo, C. L., Huang, C. S., Chang, C. S., Wu, S. L., Su, S. L., et al. (2012). Endogenous granulocyte colony-stimulating factor: a biomarker in acute ischemic stroke. Biomarkers 17, 319-324. doi: 10.3109/1354750X.2012.668712
103. Zemlan, F. P., Jauch, E. C., Mulchahey, J. J., Gabbita, S. P., Rosenberg, W. S., Speciale, S. G., et al. (2002). C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 947, 131-139. doi: 10.1016/S0006-8993(02)02920-7
104. Zimmer, D. B., Cornwall, E. H., Landar, A., and Song, W. (1995). The S100 protein family: history, function, and expression. Brain Res. Bull. 37, 417-429. doi: 10.1016/0361-9230(95)00040-2